🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT07283185
Recruiting Observational

Prospective Comparison of the Carbon Footprint of EUS vs MRCP for Evaluation of Suspected Choledocholithiasis

NCT07283185 · tracked via the Priya Life Science India tracker
Sponsor
Asian Institute of Gastroenterology, India
Phase
Observational
Started
2025-12-01
Last updated
2026-01-06

Condition(s) studied

Choledocholithiasis

Study summary

MRCP and EUS are diagnostically equivalent in detecting CBD stones among patients with intermediate risk, as shown in a landmark RCT. However, MRI-based imaging is power-intensive, requiring large infrastructure and long scan durations. EUS, a less energy-consuming and portable procedure, has the added advantage of enabling same-session ERCP, reducing the need for repeat procedures.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Intermediate likelihood of CBD stone (per ESGE) * Undergoing either MRCP or EUS for evaluation Exclusion Criteria: * High or low likelihood category (per ESGE) * Undergoing both MRCP and EUS simultaneously * Contraindications to either modality

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
AIG Hospitals Hyderabad Telangana Recruiting

More Asian Institute of Gastroenterology, India trials in India

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07283185 on ClinicalTrials.gov ↗ ← All trials in India